Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

BUY
$25.89 - $29.73 $334,369 - $383,962
12,915 Added 132.19%
22,685 $629,000
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $436,292 - $566,696
-16,697 Reduced 63.09%
9,770 $281,000
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $690,448 - $807,065
21,516 Added 434.58%
26,467 $877,000
Q4 2022

Jan 27, 2023

BUY
$41.75 - $54.5 $3,131 - $4,087
75 Added 1.54%
4,951 $254,000
Q3 2022

Nov 02, 2022

SELL
$43.76 - $53.42 $107,212 - $130,879
-2,450 Reduced 33.44%
4,876 $213,000
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $140,985 - $167,165
3,030 Added 70.53%
7,326 $384,000
Q1 2022

May 02, 2022

BUY
$45.75 - $56.69 $58,285 - $72,223
1,274 Added 42.16%
4,296 $222,000
Q4 2021

Jan 26, 2022

SELL
$41.32 - $61.25 $29,998 - $44,467
-726 Reduced 19.37%
3,022 $178,000
Q3 2021

Oct 21, 2021

SELL
$39.25 - $50.42 $117,318 - $150,705
-2,989 Reduced 44.37%
3,748 $161,000
Q2 2021

Aug 09, 2021

BUY
$35.91 - $40.68 $26,932 - $30,510
750 Added 12.53%
6,737 $264,000
Q1 2021

May 04, 2021

SELL
$33.49 - $37.77 $3,516 - $3,965
-105 Reduced 1.72%
5,987 $217,000
Q4 2020

Feb 04, 2021

SELL
$33.47 - $42.56 $17,605 - $22,386
-526 Reduced 7.95%
6,092 $224,000
Q3 2020

Oct 28, 2020

SELL
$31.75 - $37.25 $28,543 - $33,487
-899 Reduced 11.96%
6,618 $243,000
Q2 2020

Aug 07, 2020

SELL
$30.12 - $36.54 $25,662 - $31,132
-852 Reduced 10.18%
7,517 $246,000
Q1 2020

Jun 03, 2020

SELL
$27.03 - $38.62 $38,274 - $54,685
-1,416 Reduced 14.47%
8,369 $273,000
Q4 2019

Feb 12, 2020

BUY
$32.92 - $37.36 $322,122 - $365,567
9,785 New
9,785 $383,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Lloyd Advisory Services, Llc. Portfolio

Follow Lloyd Advisory Services, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lloyd Advisory Services, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Lloyd Advisory Services, Llc. with notifications on news.